Thyroid nodule natural history, complications and prognosis

Jump to navigation Jump to search


Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.

Thyroid nodule Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Thyroid nodule from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic study of choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Thyroid nodule natural history, complications and prognosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Thyroid nodule natural history, complications and prognosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Thyroid nodule natural history, complications and prognosis

CDC on Thyroid nodule natural history, complications and prognosis

Thyroid nodule natural history, complications and prognosis in the news

Blogs on Thyroid nodule natural history, complications and prognosis

Directions to Hospitals Treating Thyroid nodule

Risk calculators and risk factors for Thyroid nodule natural history, complications and prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

The most common diagnoses and their approximate distributions are colloid nodules, cysts, and thyroiditis (in 80 percent of cases); benign follicular neoplasms (in 10 to 15 percent); and thyroid carcinoma (in 5 percent).

Natural History, Complications and Prognosis

Complications

Noncancerous thyroid nodules are not life threatening. Many do not require treatment. Follow-up exams are enough. The outlook for thyroid cancer depends on the type of cancer.

Follicular carcinoma Minimally invasive follicular thyroid cancer only invasion of the capsule of the tumor without vascular invasion
Encapsulated angioinvasive follicular thyroid cancer minor vascular invasion (≤4 foci of angioinvasion within the tumor or capsule of the tumor) with or without capsular invasion
Widely invasive follicular thyroid cancer
  • Extensive invasion of the tumor capsule
  • A multinodular tumor without a well-defined capsule invading the normal thyroid surrounding the tumor
  • Extensive vascular invasion (>4 foci of angioinvasion)

Differentiated and anaplastic thyroid carcinoma TNM staging AJCC UICC 2017

Primary tumor (T)
Papillary, follicular, poorly differentiated, Hurthle cell and anaplastic thyroid carcinoma
T category T criteria
TX Primary tumor cannot be assessed
T0 No evidence of primary tumor
T1 Tumor ≤2 cm in greatest dimension limited to the thyroid
T1a Tumor ≤1 cm in greatest dimension limited to the thyroid
T1b Tumor >1 cm but ≤2 cm in greatest dimension limited to the thyroid
T2 Tumor >2 cm but ≤4 cm in greatest dimension limited to the thyroid
T3 Tumor >4 cm limited to the thyroid, or gross extrathyroidal extension invading only strap muscles
T3a Tumor >4 cm limited to the thyroid
T3b Gross extrathyroidal extension invading only strap muscles (sternohyoid, sternothyroid, thyrohyoid, or omohyoid muscles) from a tumor of any size
T4 Includes gross extrathyroidal extension
T4a Gross extrathyroidal extension invading subcutaneous soft tissues, larynx, trachea, esophagus, or recurrent laryngeal nerve from a tumor of any size
T4b Gross extrathyroidal extension invading prevertebral fascia or encasing the carotid artery or mediastinal vessels from a tumor of any size
NOTE: All categories may be subdivided: (s) solitary tumor and (m) multifocal tumor (the largest tumor determines the classification).
Regional lymph nodes (N)
N category N criteria
NX Regional lymph nodes cannot be assessed
N0 No evidence of locoregional lymph node metastasis
N0a One or more cytologically or histologically confirmed benign lymph nodes
N0b No radiologic or clinical evidence of locoregional lymph node metastasis
N1 Metastasis to regional nodes
N1a Metastasis to level VI or VII (pretracheal, paratracheal, or prelaryngeal/Delphian, or upper mediastinal) lymph nodes. This can be unilateral or bilateral disease.
N1b Metastasis to unilateral, bilateral, or contralateral lateral neck lymph nodes (levels I, II, III, IV, or V) or retropharyngeal lymph nodes
Distant metastasis (M)
M category M criteria
M0 No distant metastasis
M1 Distant metastasis
Prognostic stage groups
Differentiated
When age at diagnosis is... And T is... And N is... And M is... Then the stage group is...
<55 years Any T Any N M0 I
<55 years Any T Any N M1 II
≥55 years T1 N0/NX M0 I
≥55 years T1 N1 M0 II
≥55 years T2 N0/NX M0 I
≥55 years T2 N1 M0 II
≥55 years T3a/T3b Any N M0 II
≥55 years T4a Any N M0 III
≥55 years T4b Any N M0 IVA
≥55 years Any T Any N M1 IVB
Anaplastic
When T is... And N is... And M is... Then the stage group is...
T1-T3a N0/NX M0 IVA
T1-T3a N1 M0 IVB
T3b Any N M0 IVB
T4 Any N M0 IVB
Any T Any N M1 IVC

References

Template:WH Template:WS